Trial Profile
A Phase I, Placebo Controlled, Randomised, Double Blind Two-Way Crossover Study to Investigate the Dose Response and Efficacy of Single and Repeat Doses of GW842166 in Healthy Volunteers Using Pharmacodynamic Pain Assessments
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 27 Aug 2023
Price :
$35
*
At a glance
- Drugs GW 842166X (Primary)
- Indications Dental pain; Musculoskeletal pain
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 14 Dec 2014 Status changed from discontinued to withdrawn prior to enrolment, as reported by ClinicalTrials.gov.
- 12 Jun 2008 Status changed from initiated to discontinued as reported by ClinicalTrials.gov.
- 29 Nov 2007 New trial record.